
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Cognigenics develops innovative RNA-based gene therapies targeting memory loss, cognitive decline, anxiety associated with mild cognitive impairment and other neurocognitive and neuropsychiatric disorders. Our intranasal delivery platform targets neuronal receptors in the brain involved in CNS disorders including anxiety, and Mild Cognitive Impairment
Rna therapeutics,genetic medicines,precision genetic editing,and hyperactive neuronal receptor research
Cognigenics operates in the Biotechnology research industry.
Cognigenics's revenue is 11m - 100m
Cognigenics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.